Etoposide 100

Etoposide 100 mg Injection
Etoposide 100 mg Injection is a widely used antineoplastic agent belonging to the podophyllotoxin derivative class. It is indicated for the treatment of various malignancies and is commonly used as part of combination chemotherapy regimens. Etoposide works by inhibiting DNA synthesis in rapidly dividing cancer cells, leading to cell death.
Product Details
Generic Name: Etoposide
Strength: 100 mg
Dosage Form: Injection (Sterile solution for intravenous use)
Route of Administration: Intravenous (IV infusion)
Therapeutic Class: Antineoplastic Agent (Topoisomerase II Inhibitor)
Indications
Etoposide 100 mg Injection is indicated for the treatment of:
Small cell lung cancer
Testicular cancer
Lymphomas
Leukemia
Ovarian cancer
Other solid tumors as prescribed by an oncologist
Mechanism of Action
Etoposide inhibits the enzyme topoisomerase II, which is essential for DNA replication and repair. This results in DNA strand breaks and prevents cancer cell proliferation.
Key Benefits
Proven efficacy in multiple malignancies
Widely used in combination chemotherapy protocols
Well-established safety and efficacy profile
Suitable for global oncology treatment standards
Dosage & Administration
Dosage is determined by the oncologist based on body surface area (BSA), disease type, and patient condition. Etoposide should be administered only under the supervision of qualified healthcare professionals.
Storage Conditions
Store below 25°C
Protect from light
Do not freeze
Precautions
For hospital and oncology clinic use only
Regular monitoring of blood counts is recommended
Use with caution in patients with liver or kidney impairment